Ectd/Ctd/Actd

Prescription drug use has increased steadily in the U.S. over the last ten years. Nearly 70 percent of Americans are on at least one prescription drug and more than half of those receive at least two or more prescriptions. The amount of people who took at least one prescription drugs has accelerated 4 percent between the years 1999 and 2008. As there is a steady increase in drug consumption, drug development and regulation process should be taken more

With access to prescription drugs, people are able to treat a multitude of diseases and illnesses. These drugs help deal with pain, inability to sleep, depression, and much more. Every day we are increasingly living in a world where there is better living through chemicals. However, what most do not seem to see is the rising tide of pain, illness, and ultimately death being caused by the pills people take every day. Most keep drugs in a special place in their minds, where they see them as harmless. Sadly, this is not the case, and in some cases our prescription drugs can be just as harmful as illegal drugs (King 68).

The United States of America has had a war against drugs since the 37th president, Richard Nixon, declared more crimination on drug abuse in June 1971. From mid-1990s to today, a crisis challenges the health department and government on opioid regulation, as millions of Americans die due overdoses of painkillers. Opioids are substances used as painkillers, and they range from prescription medications to the illegal drug, heroin. Abusing these substances can cause a dependency or addiction, which can lead to overdoses, physical damages, emotional trauma, and death. To ease the crisis, physicians are asked to depend on alternatives to pain management. Law enforcement cracks down on profiting drug-dealers and heroin abusers. People are warned against misusing opioids. The controversy begins for those who suffer from chronic pain, because they depend on opioids. There’s so a correlation to the 1980s cocaine epidemic, and people are upset over racial discrimination. Nonetheless, the best way to avoid this crisis is to recover the people at risk, reduce inappropriate opioid description, and have a proper response.

P3 - Explain relevant sections of key legislation and associated guidelines with regard to the administration of medicines

P3- explain relevant sections of key legislation associated guidelines with regard to the administration of medicines

The rate of death due to prescription drug abuse in the U.S. has escalated 313 percent over the past decade. According to the Congressional Quarterly Transcription’s article "Rep. Joe Pitt Holds a Hearing on Prescription Drug Abuse," opioid prescription drugs were involved in 16,650 overdose-caused deaths in 2010, accounting for more deaths than from overdoses of heroin and cocaine. Prescribed drugs or painkillers sometimes "condemn a patient to lifelong addiction," according to Dr. Tom Frieden, director of the U.S. Centers for Disease Control and Prevention. This problem not only affects the lives of those who overdose but it affects the communities as well due to the convenience of being able to find these items in drug stores and such.

Consult www.phrma.org, The Pharmaceutical Research and Manufacturers of America. What steps is the branded industry taking to address the

Specific purpose: To inform my audience about the growing problem of prescription drug abuse, some common drugs that cause abuse, and their effects and some common treatments.

Opioid analgesics are the widely prescribed medications for both non-cancer and cancer-related pain. Opioid dugs provide significant benefit for patients, when they used for their approved indications. However, opioids are also carries the risk of abuse, misuse and death. In 2009, more than 15,500 people died in the United States due to overdose of narcotic pain relievers. In order to combat the opioid misuse, abuse, and addiction, FDA has taken many steps to address this problem over the last few decades. The task force’s multi- pronged approach targets, drug development, opioid labeling, prescriber education, patient education, exploring innovative packaging and storage to prevent abuse, encouraging the development of products that treat abuse and overdose and role of other agencies.

ESSENCE OF THE STORY: In the past few years, opioid addiction has become an epidemic in the United States leading to around 64,000 people dying from drug overdose in 2016 alone. As a result the health and human services secretary, Mr. Azar, and the F.D.A. chief, Dr. Scott Gottlieb, has made battling opioid addiction a top priority. The main way the F.D.A. is attempting to battle the epidemic is by allowing pharmaceutical companies to sell new types of medications that aren’t meant to stop addiction but to help suppress the cravings of addiction. The new medication that the F.D.A is approving is supposed to be a part of the program MAT, or medication-assisted-treatment. Mr. Azar as well as Dr. Scott have been pushing for more MAT in hope to help people with addiction live productive lives. Though like most big changes in society, the F.D.A’s decision has drawn criticism. Addiction experts are saying that new medication isn’t the solution but more access to the medication is.

This distinction, between the legitimate use of psychoactive medicines and the sub rosa use of drugs, is more vexed than ever. We have seen nearly 45 years of the War of Drugs… outcries about the safety of our children and accompanying uproars about nicotine in e-cigarettes, caffeine in energy drinks, “synthetic marijuana”, and heroin… club drugs, designer drugs, experimental drugs, homemade methamphetamine… We have pharmaceutical commercials on TV…to the point that any thinking person would be forgiven for questioning the

The use of controlled substances continues to be a problem within the healthcare industries. As healthcare provider, we are more concerned with pleasing the patients by giving into their demands and improving the organization’s Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHAPS) scores that we get lost in why we chose to go into the healthcare profession, to save people lives and do no

Prescription drug abuse and misuse is becoming a major public health issue in the United

People all over the world, continue to be tendered prescription medication, which in many cases further complicate health issues with its myriad of side effects. In fact, statistics have shown that approximately 100,000 people around the world die as a result of prescription drugs annually (Smith, 2012). On the contrary, according

A contract manufacturing company has been analysing a tablet product by the method described in the British Pharmacopoeia (BP) monograph. This is the method detailed on the product License and BP methods are generally considered to be validated. After trend analysis for the annual Product Quality Review (PQR) report, it has been discovered that 5 batches were rejected in 2013 due to high out of specification assay results. Furthermore, several batches had assay values close to the upper specification limit. The release specification limits for the product are 95-105%.